Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.

The ARIES-HM3 trial analysis found that in advanced heart failure patients with traditional indications for antiplatelet ...

For decades, taking low-dose aspirin every day was widely recommended as an easy way to prevent heart attacks and strokes. But that advice has changed.

Scientists at UMass Amherst and Ernest Pharmaceuticals developed BacID, a bacterial cancer therapy activated by aspirin. This ...

People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...

Expected to begin in 2027, the trials will involve human patients, and the researchers are working to obtain the necessary ...

In the United States, the annual consumption of aspirin is approximately 80 billion tablets, while in the United Kingdom it is approximately 100 tons. Apart from its analgesic and antipyretic ...

A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made "exciting," patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver ...

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...